CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
85.97%
Total 13F principal
$295,334,000
Principal change
-$1,313,000
Total reported market value
$258,639,000
Number of holders
24
Value change
-$31,281,590
Number of buys
11
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q4 2015

As of 31 Dec 2015, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 24 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $295,334,000 in principal (par value) of the bond. The largest 10 bondholders included BAKER BROS. ADVISORS LP, WOLVERINE ASSET MANAGEMENT LLC, QVT Financial LP, CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, LAZARD ASSET MANAGEMENT LLC, Allianz Asset Management AG, ADVENT CAPITAL MANAGEMENT /DE/, UBS OCONNOR LLC, and Telemetry Investments, L.L.C.. This page lists 24 institutional bondholders reporting positions for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.